Summary & Overview
HCPCS Level II J0206: Allopurinol Sodium Injection, 1 mg
HCPCS Level II code J0206 denotes an injectable formulation of allopurinol sodium, billed at 1 mg per unit. The code identifies supply of the medication for parenteral administration and matters nationally because injectable formulations of urate-lowering therapy can affect drug procurement, billing workflows, and site-of-service reimbursement across outpatient and hospital settings. Payers commonly involved in coverage and payment decisions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
This publication provides a concise overview of clinical context for parenteral allopurinol sodium, the typical sites where the service is delivered, and the operational implications for billing departments. Readers will find benchmarks and policy-relevant information where available, an outline of common modifiers used with injectable drug supply codes, and guidance on documentation elements that payers typically expect. The analysis addresses national payer considerations rather than state-specific rules and highlights areas where billing teams should confirm payer-specific policies. Data not available in the input will be indicated where applicable.
Billing Code Overview
HCPCS Level II code J0206 represents an injection of allopurinol sodium, billed per 1 mg of the drug. The service is a pharmacologic injectable therapy used for urate-lowering treatment in clinical settings that administer parenteral medications.
Service Type: Injectable drug administration / drug supply
Typical Site of Service: Outpatient infusion clinic, physician office, hospital outpatient department, or other sites where parenteral medications are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with refractory gout or hyperuricemia who requires parenteral urate-lowering therapy when oral allopurinol is contraindicated, not tolerated, or when rapid stabilization of serum uric acid is clinically indicated. The patient presents to an outpatient infusion clinic, ambulatory surgical center, or hospital outpatient department for a scheduled injection. Pre-procedure workflow includes verification of indication, review of allergy history and prior adverse reactions to xanthine oxidase inhibitors, medication reconciliation, baseline vital signs, and informed consent for an injectable biologic/small-molecule agent. A nurse or licensed clinician prepares the dose using J0206 billed per milligram, verifies the patient identity and IV or subcutaneous access as required, administers the injection, monitors for immediate hypersensitivity for 30–60 minutes, documents lot number and expiration, and provides post-injection instructions. Billing is submitted with the HCPCS Level II code J0206 (Injection, allopurinol sodium, 1 mg) and appropriate diagnosis codes supporting the medical necessity of urate-lowering therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | When part of a single-use vial is discarded and payer requires separate reporting of discarded controlled or non-controlled drug quantities. |